Advertisement

Topics

Hannover Re US Company Profile

03:46 EDT 19th June 2019 | BioPortfolio

Hannover Life Reassurance Company of America (Hannover Re US), which is licensed and/or accredited in all 50 states, the District of Columbia, Puerto Rico and Guam, is the North American life and health reinsurance subsidiary of the Hannover Re Group. Hannover Re, with gross premium of EUR 16.4 billion, is the third-largest reinsurer in the world. It transacts all lines of property & casualty and life & health reinsurance and is present on all continents with around 2,900 staff and a network of more than 100 subsidiaries, branches and representative offices. The rating agencies most relevant to the insurance industry have awarded Hannover Re very strong insurer financial strength ratings (Standard & Poor's AA- "Very Strong" and A.M. Best A+ "Superior"). For more information, visit www.hannover-re.com.


News Articles [30 Associated News Articles listed on BioPortfolio]

„Schaufenster Bioökonomie“ – Hannover Messe präsentiert biobasierte Produkte und Forschungshighlights

Aktuelle Produktinnovationen und neueste Forschungsergebnisse in der Bioökonomie locken zahlreiche Besucher auf die Hannover Messe. Weitere Veranstaltungsformate, so die International Bioeconomy Conf...

Hannover Messe 2019

Die neue Boeing 737 MAX 8 von TUI trägt den Namen "Kittilä"

Hannover (ots) - - Querverweis: Bildmaterial wird über obs versandt und ist abrufbar unter http://www.presseportal.de/bilder - - Die neuen Flugzeuge des Unternehmens werden zu fliegenden Botschafte.....

Tui lässt Boeing-Max-8 in der Luft - besorgte Passagieranfragen

Gestützt auf Empfehlungen der US-Luftfahrtbehörde FAA lässt der Tui-Konzern aus Hannover seine 15 Flugzeuge vom Typ Boeing 737 Max 8 weiter fliegen. Anders als zahlreiche andere Airlines weltweit ....

ROUNDUP 2/Flugverbote für Boeing-Jets: Reiseriese Tui rechnet mit Gewinneinbruch

(neu: Aussagen aus Telefonkonferenz zu Dividende, Buchungsrückgang, Ersatzflugzeugen, aktualisierter Aktienkurs) HANNOVER (dpa-AFX) - Die Flugverbote für Boeings Mittelstreckenjet 737 Max durchkre.....

Aktien: Bayer an der DAX-Spitze, Deutsche Bank und Wirecard am Ende

Hannover (www.aktiencheck.de) - Gewinnmitnahmen charakterisierten am Donnerstag den deutschen Aktienmarkt (DAX (ISIN DE0008469008/ WKN 846900) -0,25%, MDAX (ISIN DE0008467416/ WKN 846741) -0,64%, T...

Aktien: Munich Re am DAX-Ende, Kursgewinne bei Bayer und VW

Hannover (www.aktiencheck.de) - Am deutschen Aktienmarkt (DAX (ISIN DE0008469008/ WKN 846900) +0,01%, MDAX (ISIN DE0008467416/ WKN 846741) -0,63%, TecDAX (ISIN DE0007203275/ WKN 720327) -0,9%) tat ...

Aktien: Infineon an der DAX-Spitze, Bayer am Ende

Hannover (www.aktiencheck.de) - Die Aussicht, doch noch eine Einigung bei den Brexit-Verhandlungen zu erzielen, hat den deutschen Aktienmarkt (DAX (ISIN DE0008469008/ WKN 846900) +1,30%, MDAX (ISIN...

Drugs and Medications [0 Results]

None

PubMed Articles [4 Associated PubMed Articles listed on BioPortfolio]

Implementing LOINC: Current Status and Ongoing Work at the Hannover Medical School.

The Logical Observation Identifiers, Names and Codes (LOINC) is a common terminology used for standardizing laboratory terms. Within the HiGHmed consortium, LOINC is used as a central terminology for ...

2018 international meeting of the Global Virus Network.

The Global Virus Network (GVN) was established in 2011 to strengthen research and responses to emerging viral causes of human disease and to prepare against new viral pandemics. There are now 45 GVN C...

Challenges in Long-Term Follow-Up Care of Patients After Kidney Transplantation in Specialized Transplant Centers.

Medical care after kidney transplantation requires a close follow-up in specialized transplant centers to minimize complications. Especially in bigger territorial states, the distance the patients hav...

Effects of 17β-HSD2 inhibition in bones on osteoporosis based on an animal rat model.

Hormone replacement therapy is a viable option to protect bone from postmenopausal osteoporosis. Systemically elevated estrogen levels, however, are disadvantageous because of the risk of harmful side...

Clinical Trials [8 Associated Clinical Trials listed on BioPortfolio]

Auditory Midbrain Implant Study

The objectives of the clinical study are to implant five deaf patients (those with Neurofibromatosis Type II, NF2) with a new two-shank auditory midbrain implant array (AMI; developed by C...

Observation of Initial Procalcitonin and the Clinical Course of Patients With Acute Respiratory Tract Infections

Observation of the initial Procalcitonin values and the clinical course of consecutively included patients with Acute Respiratory Tract Infections at general medical practices in greater H...

723/726 Proof of Concept Study in Allergen Challenge Chamber in Hannover

This is a randomised, double-blind, placebo-controlled 4-period cross-over study to assess the efficacy and safety of repeat dose intranasal GSK1004723 (1000µg), oral GSK835726 (10mg) and...

Upper and Lower Airway Colonization in Cystic Fibrosis Patients After Lung Transplantation

A hot topic in lung transplantation is the treatment of persisting sinus disease/colonization in CF patients to prevent descending graft colonization and chronic allograft dysfunction. Fro...

Dual Guidance Structure for Evaluation of Patients With Unclear Diagnosis in Centers for Rare Diseases

In people suffering from a rare disease the diagnostic process and the confirmation of a final diagnosis is often ongoing for many years. Factors contributing to delayed diagnosis include ...

Companies [7 Associated Companies listed on BioPortfolio]

Hannover Re US

Hannover Life Reassurance Company of America (Hannover Re US), which is licensed and/or accredited in all 50 states, the District of Columbia, Puerto Rico and Guam, is the North A...

Hannover Medical School (MHH)

The Hannover Medical School, founded in 1965, is one of the world's leading university medical centres. Our research and patient care set national and international standards. We are also part of an e...

Hannover Life Reassurance Company of America

BIOTECHNICA

BIOTECHNICA mirrors the successful development of one of the most important sectors of the future. More and more exhibitors and visitors from across the globe are taking advantage of Europe's leading ...

Pharis Biotec GmbH

"Pharis is a biotechnological-biopharmaceutical group of companies with the aim of isolating and modifying new body-own peptides and proteins as substances, which can be produced in a suitable form to...

More Information about "Hannover Re US" on BioPortfolio

We have published hundreds of Hannover Re US news stories on BioPortfolio along with dozens of Hannover Re US Clinical Trials and PubMed Articles about Hannover Re US for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Hannover Re US Companies in our database. You can also find out about relevant Hannover Re US Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record